Jump to main content
Jump to site search


Biomimetic nanoparticle technology for cardiovascular disease detection and treatment

Author affiliations

Abstract

Cardiovascular disease (CVD), which encompasses a number of conditions that can affect the heart and blood vessels, presents a major challenge for modern-day healthcare. Nearly one in three people has some form of CVD, with many suffering from multiple or intertwined conditions that can ultimately lead to traumatic events such as a heart attack or stroke. While the knowledge obtained in the past century regarding the cardiovascular system has paved the way for the development of life-prolonging drugs and treatment modalities, CVD remains one of the leading causes of death in developed countries. More recently, researchers have explored the application of nanotechnology to improve upon current clinical paradigms for the management of CVD. Nanoscale delivery systems have many advantages, including the ability to target diseased sites, improve drug bioavailability, and carry various functional payloads. In this review, we cover the different ways in which nanoparticle technology can be applied towards CVD diagnostics and treatments. The development of novel biomimetic platforms with enhanced functionalities is discussed in detail.

Graphical abstract: Biomimetic nanoparticle technology for cardiovascular disease detection and treatment

Back to tab navigation

Publication details

The article was received on 05 May 2019, accepted on 28 Jun 2019 and first published on 28 Jun 2019


Article type: Review Article
DOI: 10.1039/C9NH00291J
Nanoscale Horiz., 2019, Advance Article

  •   Request permissions

    Biomimetic nanoparticle technology for cardiovascular disease detection and treatment

    J. H. Park, D. Dehaini, J. Zhou, M. Holay, R. H. Fang and L. Zhang, Nanoscale Horiz., 2019, Advance Article , DOI: 10.1039/C9NH00291J

Search articles by author

Spotlight

Advertisements